Becton Dickinson & Co (BDX)

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Symbol
BDX
Exchange
NYSE
Sector
Healthcare
Industry
Medical Instruments & Supplies
Market cap
$48.16B
52 week range
127.59 - 193.07

Valuation

Share price
$176.80 (close of 2026-10-02)
P/E (TTM)
53.41x
Price to book
1.97x
Price to free cash flow
15.04x
Enterprise value
$64.26B
Book value per share
$89.64

Price performance

PeriodChange
1 day-0.71%
5 days-3.82%
1 month-5.72%
3 months+11.84%
6 months+14.43%
Year to date+15.88%
1 year+17.37%
3 years-12.75%
5 years-5.79%
10 years+28.26%
All time+9832.58%

Members of Congress who disclosed BDX trades

Lisa McClain · Robert Bresnahan · Thomas Kean · Alan Armstrong · Jefferson Shreve · Kevin Hern

Super investors holding BDX

First Eagle Investment (First Eagle Investment Management, LLC) · Greenhaven Associates (Greenhaven Associates Inc) · Bill Nygren (Harris Associates LP) · First Pacific Advisors (First Pacific Advisors, LP) · Ken Griffin (Citadel) · Robert Olstein (Olstein Capital Management) · Hillman Capital (Hillman Capital Management, Inc) · Ray Dalio (Bridgewater Associates) · Mairs & Power (Mairs & Power Inc)

Profitability and growth

Return on equity
6.61%
Return on invested capital
5.41%
Return on assets
3.03%
Return on capital employed
5.49%
Gross margin
45.44%
Net margin
7.68%
EBITDA margin
23.08%
Revenue growth
8.24%
Net income growth
-1.58%
Free cash flow growth
-14.40%

Cash flow and balance sheet

Free cash flow yield (TTM)
6.65%
Current ratio
0.87x
Net debt to EBITDA
3.65x

Latest reported year

Period end
2025-09-30
Fiscal year
2025
Revenue
$21.84B
Cost of revenue
$11.91B
Gross profit
$9.93B
EBITDA
$5.04B
Net income
$1.68B
Earnings per share
$5.83
Research and development
$1.26B
Interest expense
$613.00M
Shares outstanding
287.65M

Income statement by year

Period endRevenueGross profitNet incomeEPS
2025-09-30$21.84B$9.93B$1.68B$5.83
2024-09-30$20.18B$9.13B$1.71B$5.88
2023-09-30$19.37B$8.17B$1.48B$4.97
2022-09-30$18.87B$8.48B$1.78B$5.93
2021-09-30$19.13B$8.63B$2.09B$6.92
2020-09-30$16.07B$7.58B$874.00M$2.75
2019-09-30$17.29B$8.29B$1.23B$4.01
2018-09-30$15.98B$7.27B$311.00M$0.62
2017-09-30$12.09B$5.94B$1.10B$4.70
2016-09-30$12.48B$5.99B$976.00M$4.59

Margins and returns by year

Period endGross marginNet marginReturn on equityReturn on capital
2025-09-3045.44%7.68%6.61%5.41%
2024-09-3045.22%8.45%6.59%4.74%
2023-09-3042.17%7.66%5.75%4.92%
2022-09-3044.92%9.43%7.04%5.29%
2021-09-3045.12%10.94%8.84%5.48%
2020-09-3047.14%5.44%3.68%2.16%
2019-09-3047.94%7.13%5.85%4.41%
2018-09-3045.48%1.95%1.48%1.82%
2017-09-3049.14%9.10%8.50%8.63%
2016-09-3047.99%7.82%12.79%7.56%

Cash and debt by year

Period endCashDebt
2025-09-30$641.00M$17.62B
2024-09-30$1.72B$17.94B
2023-09-30$1.42B$14.74B
2022-09-30$1.01B$13.89B
2021-09-30$2.28B$17.11B
2020-09-30$2.83B$17.22B
2019-09-30$536.00M$18.08B
2018-09-30$1.14B$18.89B
2017-09-30$14.18B$18.67B
2016-09-30$1.54B$10.55B

Free cash flow by year

Period endFree cash flowStock-based compensation
2025-09-30$2.67B$258.00M
2024-09-30$3.12B$247.00M
2023-09-30$2.12B$259.00M
2022-09-30$1.50B$233.00M
2021-09-30$3.45B$229.00M
2020-09-30$2.77B$236.00M
2019-09-30$2.37B$261.00M
2018-09-30$1.97B$322.00M
2017-09-30$1.82B$174.00M
2016-09-30$1.87B$196.00M

Dividend history

Most recent payment
2026-09-09
Paid in the last twelve months
$4.20
Payment dateDividend per share
2026-09-09$1.05
2026-06-09$1.05
2026-03-10$1.05
2025-12-08$1.05
2025-09-08$1.04
2025-06-09$1.04
2025-03-10$1.04
2024-12-09$1.04

Investor relations

Next earnings report

Next confirmed report
2026-11-05
Consensus EPS estimate
$4.06

Past earnings dates

ReportedFiscal periodEPS estimate
2026-08-06Jun/2026$3.14
2026-05-07Mar/2026$2.77
2026-02-09Dec/2025$2.82
2025-11-06Sep/2025$3.92
2025-08-07Jun/2025$3.42
2025-07-30--
2025-05-01Mar/2025$3.28
2025-04-30--

Filings and sources

Company website
bd.com
SEC filings
10-K, 10-Q and 8-K on EDGAR
Earnings calendar
All upcoming reports

Similar companies

ResMed Inc (RMD) · Intuitive Surgical Inc (ISRG) · Alcon Inc (ALC) · Medline Inc. (MDLN) · West Pharmaceutical Services Inc (WST) · Henry Schein Inc (HSIC) · Cardinal Health Inc (CAH) · Cencora, Inc. (COR)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades